4-Bromo-6-ethyl-5-fluoropyrimidine

Catalog No.: 
ACCTEB542
CAS No.: 
1702684-04-5
Molecular Formula: 
C6H6BrFN2
Molecular Weight: 
205.03
4-Bromo-6-ethyl-5-fluoropyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$206.00In stockInquiry
1g95%$599.00In stockInquiry
5g95%$2156.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-6-ethyl-5-fluoropyrimidine
IUPAC Name4-Bromo-6-ethyl-5-fluoropyrimidine
Molecular FormulaC6H6BrFN2
Molecular Weight205.03
SMILESFC1=C(CC)N=CN=C1Br
InChI KeyBMGRIXHBRZQSQW-UHFFFAOYSA-N
SynonymVoriconazole Impurity 53;Voriconazole Impurity 55;VoricozoleImpurity14;Pyrimidine, 4-bromo-6-ethyl-5-fluoro-;Voriconazole impurity 37;4-bromo-6-ethyl-5-fluoropyrimidine
CAS No.1702684-04-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338-P405-P501

Synthetic Route by SureRoute

1. ACCTEB542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTEB542 route product structure diagram
    ACCTEB5421702684-04-5In Stock
Inquiry

2. ACCTEB542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTEB542 route product structure diagram
    ACCTEB5421702684-04-5In Stock
Inquiry

3. ACCTEB542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTEB542 route product structure diagram
    ACCTEB5421702684-04-5In Stock
Inquiry

Comments (0)